NTAGI panel reviews data for Biological E Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma22 July 2022 3:30 PM ISTIndia's first indigenously developed RBD protein subunit vaccine, Corbevax, is currently being used to inoculate children in the age group of 12 to 14...
Covishield demand down under Covax Rahul Verma13 July 2022 3:07 PM ISTAs per a document on the World Health Organization (WHO)- supported global Covid vaccine facility, Serum Institute of India's COVID vaccine...
NTAGI to discuss data of Gennova Pharma mRNA vaccine against COVID Ruchika Sharma12 July 2022 1:00 PM ISTThe indigenous innovative mRNA vaccine is based on the second wave driven by the Delta variant and can be kept under 2 to 8 degrees Celsius this means...
NTAGI to discuss allowing Biological Corbevax as booster for Covishield, Covaxin recipients Ruchika Sharma28 Jun 2022 9:00 AM ISTCORBEVAX is a protein sub-unit vaccine, developed from a component of the spike protein on the virus's surface, which helps the body build the immune...
DCGI nod to Biological E Corbevax as heterologous COVID booster Ruchika Sharma5 Jun 2022 12:00 PM ISTBE's CORBEVAX is the first such vaccine in India to be approved as a heterologous COVID-19 booster.
Health Bulletin 12/May/2022 Dr. Nandita Mohan12 May 2022 5:22 PM ISTHere are the top health stories for the day: Dr. Archana Sharma medLegal helpdesk' launched by IML to make doctors aware of...
Biological E seeks DCGI emergency use nod for Corbevax as booster in adults vaccinated with Covaxin, Covishield Ruchika Sharma12 May 2022 1:40 PM ISTAccording to the EUA application submitted to DCGI, Biological E in a phase-3 placebo-controlled clinical study, based on the drug regulator's nod,...
Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial for 2-18 age group Ruchika Sharma5 May 2022 12:34 PM ISTThe study is likely to be conducted at six sites, including AIIMS Delhi and Patna.
SC finds no haste in granting EUA to covishield, covaxin MD Bureau3 May 2022 1:08 PM ISTThe bench said: "The material provided by the Union of India, comprising minutes of the meetings of the SEC, do not warrant the conclusion that...
Bharat Biotech must address WHO's Covaxin suspension to avoid emergency use approval cancellation: MEA Ruchika Sharma29 April 2022 10:00 AM ISTThe communication stated that a proper response or policy from the government needs to be formulated on the issue and on further pursuance of...
Use 10 cr Covishield doses offered free of cost by GAVI: SII urges Centre Ruchika Sharma25 April 2022 11:00 AM ISTThe cumulative COVID-19 vaccine doses administered in the country has so far exceeded 187.67 crore.
Serum Institute CEO warns against return to business-as-usual approach Ruchika Sharma23 April 2022 10:30 AM IST"The momentum of the past that brought us so far here is lost. As you said it seems for them, it's business as usual," Poonawalla said.
